PIAS2-2 SUMOylates THRA with SUMO3

Stable Identifier
R-HSA-4719423
Type
Reaction [transition]
Species
Homo sapiens
Compartment
nucleoplasm
ReviewStatus
5/5
Locations in the PathwayBrowser
Expand all
General
SVG | 
PNG
Low
Medium
High
 | PPTX  | SBGN
PIAS2-2 SUMOylates THRA with SUMO3
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
PIAS2-2 (PIasx-alpha) SUMOylates THRA (isoform alpha-1) with SUMO3 at lysine-283 and lysine-389 (Liu et al. 2012). (A lysine residue corresponding to lysine-389 does not exist in the alpha-2 isoform of THRA.) SUMOylation by SUMO3 enhances transcription in response to ligand binding.
Literature References
PubMed ID Title Journal Year
22930759 Thyroid hormone receptor isoform-specific modification by small ubiquitin-like modifier (SUMO) modulates thyroid hormone-dependent gene regulation

Schultz, JJ, Liu, YY, Kogai, T, Mody, K, Brent, GA

J. Biol. Chem. 2012
Participants
Input
Output
Participates
as an event of
Catalyst Activity

SUMO transferase activity of PIAS2-2 [nucleoplasm]

Physical Entity
PIAS2-2 [nucleoplasm] (Homo sapiens)
Activity
SUMO transferase activity (GO:0019789)
Orthologous Events
PIAS2-2 SUMOylates THRA with SUMO3 (Bos taurus)
PIAS2-2 SUMOylates THRA with SUMO3 (Drosophila melanogaster)
PIAS2-2 SUMOylates THRA with SUMO3 (Gallus gallus)
PIAS2-2 SUMOylates THRA with SUMO3 (Mus musculus)
PIAS2-2 SUMOylates THRA with SUMO3 (Rattus norvegicus)
PIAS2-2 SUMOylates THRA with SUMO3 (Sus scrofa)
Authored
May, B  (2013-10-18)
Reviewed
Niskanen, E  (2018-05-09)
Niskanen, E  (2018-08-08)
Created
May, B  (2013-10-19)
Cite Us!